Transplantation of cancer-resistant mouse immune system cells provides antitumor protection
- Authors: Bersenev A.V.
- Issue: Vol 1, No 3 (2006)
- Pages: 14-14
- Section: Cell technology
- Submitted: 20.02.2023
- Accepted: 20.02.2023
- Published: 15.03.2006
- URL: https://genescells.ru/2313-1829/article/view/255645
- DOI: https://doi.org/10.23868/gc255645
- ID: 255645
Cite item
Open Access
Access granted
Full Text
About the authors
A. V. Bersenev
Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation
References
- Morris E., Hart D., Gao L. et al. Generation of tumor-specific T-cell therapies. Blood Rev. 2006; 20[2): 61-9.
- Ruggeri L., Mancusi A., Capanni M. et al. Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. Curr. Opin. Immunol. 2005; 17[2): 211-7.
- Koehl U., Sorensen J., Esser R. et al. IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation. Blood Cells Mol. Dis. 2004; 33[3): 261-6.
- Cui Z., Willingham M.C., Hicks A.M. et al. Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice. Proc. Natl. Acad. Sci. USA 2003; 100[11 ): 6682-7.
Supplementary files
